---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-027017"
form_type: "8-K"
ticker: "VICP"
cik: "0001468639"
company_name: "Vicapsys Life Sciences, Inc."
filed_at: "2022-09-28T23:59:59+00:00"
generated_at: "2026-06-23T06:57:19.745185+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Vicapsys Life Sciences: Potts and Yurkowsky resign; Farrahar, Delaney, Rosenblum join board

## Summary
- Board accepted resignations of directors John Potts and Michael Yurkowsky effective September 22, 2022; no disagreement.
- Appointed Charles 'Charlie' Farrahar (CPA, former CFO of several biotechs) as director.
- Appointed Dr. Colleen Delaney, stem cell transplant physician and CSO of Deverra Therapeutics, as director.
- Appointed Richard Rosenblum, President/CFO of Payment Solutions Inc. and CEO of Harborview Capital Advisors, as director.

## SEC filing metadata
- accession: 0001493152-22-027017
- form_type: 8-K
- ticker: VICP
- cik: 0001468639
- company_name: Vicapsys Life Sciences, Inc.
- filed_at: 2022-09-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468639/000149315222027017/0001493152-22-027017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468639/000149315222027017/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-027017
- JSON: https://secwatch.observer/filing/0001493152-22-027017.json
- Plain text: https://secwatch.observer/filing/0001493152-22-027017.txt

## Key facts
- Executive change
  Richard Rosenblum was appointed as director at Vicapsys Life Sciences, Inc..
  - Action: appointed
  - Role: director
  source text: appointed each of Charles “Charlie” Farrahar, Dr. Colleen Delaney and Richard Rosenblum as members of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468639/000149315222027017/0001493152-22-027017-index.htm
- Executive change
  John Potts resigned as director at Vicapsys Life Sciences, Inc..
  - Action: resigned
  - Role: director
  source text: accepted the resignations of John Potts and Michael Yurkowsky as members of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468639/000149315222027017/0001493152-22-027017-index.htm
- Executive change
  Michael Yurkowsky resigned as director at Vicapsys Life Sciences, Inc..
  - Action: resigned
  - Role: director
  source text: accepted the resignations of John Potts and Michael Yurkowsky as members of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468639/000149315222027017/0001493152-22-027017-index.htm
- Executive change
  Colleen Delaney was appointed as director at Vicapsys Life Sciences, Inc..
  - Action: appointed
  - Role: director
  source text: appointed each of Charles “Charlie” Farrahar, Dr. Colleen Delaney and Richard Rosenblum as members of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468639/000149315222027017/0001493152-22-027017-index.htm
- Executive change
  Charles Farrahar was appointed as director at Vicapsys Life Sciences, Inc..
  - Action: appointed
  - Role: director
  source text: appointed each of Charles “Charlie” Farrahar, Dr. Colleen Delaney and Richard Rosenblum as members of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468639/000149315222027017/0001493152-22-027017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.